At SK bioscience, we continue investments to secure innovative technologies
and advanced manufacturing systems.
We have successfully created commercial vaccines
and have become a trusted global partner based on our achievements.
Given our innovative achievements in the vaccine markets,
and our preparations to respond to endemic outbreaks and the next pandemic,
we are attracting interest from governments,
institutions and companies around the world.

Now, we are embracing the next-level challenges
that will accelerate another leap in our development.